Growth Hormone Peptide Telehealth
Physician-guided evaluation for growth hormone–signaling peptide therapies when clinically appropriate.
$99 Consultation | $300 Total If Approved
Understanding Growth Hormone Signaling Peptides
Growth hormone–signaling peptides are compounds studied for their influence on endogenous growth hormone pathways.
Through telehealth, licensed providers assess whether these therapies may be appropriate based on individual medical history and goals.
Compounded peptide medications are not FDA-approved for the diagnosis, treatment, cure, or prevention of disease.
Peptides We Evaluate For
Each therapy requires physician evaluation and is prescribed only when clinically appropriate.
Who Typically Seeks Growth Hormone Peptide Evaluation?
- Are physically active
- Prioritize recovery and performance
- Seek physician-guided oversight
- Prefer regulated pharmacy fulfillment
- Want structured evaluation instead of self-directed sourcing
Appropriateness is determined only after consultation.
How It Works
You’ll begin with a brief virtual consultation with a licensed medical provider, who will review your medical history and determine whether this therapy may be appropriate for you.
If treatment is recommended, your prescription is sent to a licensed U.S. compounding pharmacy and shipped directly to your home, typically within 3–7 business days.
Consultation Cost
The total cost is $300, which includes:
If a peptide therapy is not clinically appropriate, there is no charge for the visit.
- All therapies are prescribed only when clinically appropriate and based on physician evaluation.
Medical & Regulatory Considerations
Growth hormone–signaling peptides offered via telehealth may be compounded.
Compounded medications are not FDA-approved and may have limited long-term human safety data.
These therapies are prescribed based on individualized physician judgment.
The FDA has not evaluated statements on this website.
Individual results vary.
Frequently Asked Questions
Some peptides are studied for their influence on endogenous growth hormone signaling pathways. Clinical effects vary and depend on individual physiology.
No. Growth hormone–signaling peptides differ from recombinant human growth hormone and operate through different biological pathways.
No. Prescriptions are issued only after physician evaluation and clinical approval.
Compounded peptide therapies are not FDA-approved for the diagnosis, treatment, cure, or prevention of disease.
Ready to Discuss Growth Hormone Peptide Options?
Schedule your $99 consultation and speak with a licensed provider.